Back to UBS Group AG UBS Group AG

AMRXAMRX
Showing 8 of 30 quarters

Position history for UBS Group AGUBS Group AG's holdings in AMNEAL PHARMACEUTICALS INC

UBS Group AG holds 444,400 shares of AMRX (AMNEAL PHARMACEUTICALS INC), worth $7.7M as of 2026-Q2. The position was decreased (-47.2% shares). AMRX represents 0.0% of UBS Group AG's portfolio.

Current Value

$7.7M

Current Shares

444,400

Total Value Change

-$173.5M

Total Shares Change

-21.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
444,400
-47.2%
$7.7M0.0%$17.31
0
2026-Q1
Decreased
840,958
-10.1%
$10.5M0.0%$13.31
0
2025-Q4
Decreased
935,479
-35.3%
$11.8M0.0%$12.88
0
2025-Q3
Decreased
1.4M
-8.7%
$14.5M0.0%$9.87
0
2025-Q2
Decreased
1.6M
-12.7%
$12.8M0.0%$8.13
0
2025-Q1
Increased
1.8M
+8.8%
$15.2M0.0%$8.28
31
2024-Q4
Decreased
1.7M
-92.3%
$13.2M0.0%$7.83
0
2024-Q3
Decreased
21.8M
-0.3%
$181.2M0.0%$8.19
0

Other major holders of AMRX: BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, VANGUARD PORTFOLIO MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used